| mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
1e-09 |
| mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
9e-08 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-07 |
| mRNA |
BRD-K88742110 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-07 |
| mRNA |
Zebularine |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-07 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
2e-07 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-07 |
| mRNA |
pifithrin-alpha |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-07 |
| mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-06 |
| mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-06 |